Phase 4 N=30 Progestin-Only Pill Use and Breastfeeding Study
Contraception · Breastfeeding
Primary: Exclusive Lactation Among Birthing People at 8 Weeks Postpartum. — 7; 7; 6 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=17 Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
Keratitis
Primary: Correlation Between the Change From Baseline in VMR Measured With FVA System at Month 3 and the Change From Baseline in the CFS at Month 3. — -0.7028 Spearman's…
Phase 4 N=30 Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation
Mydriasis
Primary: Mean Change in Pupil Diameter — 3.73; 6.46 millimeters
Phase 4 N=40 A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
Asthma
Primary: Change From Baseline to Week 12 in Constant Work Rate Exercise Endurance Time - CWRET (Constant Work Rate Exercise Test) — 0.923; 1.742 Minutes
Phase 4 N=50 Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis
Psoriasis
Primary: Psoriasis Area Severity Index 75 at Week 12 — 29 Participants
Phase 4 N=15 Buprenorphine Loading in the Emergency Department
Opioid-use Disorder
Primary: Number of Participants With Successful Rapid Induction — 14 Participants
Phase 4 N=48 Double Pick up in Poor Prognosis Women
Fertility Disorders
Primary: Number of MII Oocytes Retrieved Between the Two Arms — 4.1; 3.0 number of oocytes
Phase 4 N=33 Effectiveness of Cervical Transforaminal Epidural Steroid Injection
Cervical Radiculopathy · Cervical Spondylosis · Disk, Herniated
Primary: Percentage of Participants Reporting ≥50% Reduction in Index Numeric Rating Scale (NRS) Arm Pain Score — 19; 23; 20; 20 Participants
Phase 4 N=20 Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
Psoriasis
Primary: Investigator Global Assessment (Scalp Only) — 1.59 score on a scale
Phase 4 N=9 Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Heart Failure · Heart Failure, Diastolic · Heart Failure With Preserved Ejection Fraction
Primary: Features of a Feasible and Pragmatic Protocol for Deprescribing N-of-1 Trials in Patients With Heart Failure With Preserved Ejection Fraction, as Measured by Qualitative…
Phase 4 N=65 Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression
Bipolar Depression
Primary: Response to Treatment — 21; 9; 6; 11 Participants — p=.02
Phase 4 N=17 Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
Verruca Vulgaris · Molluscum Contagiosum Skin Infection
Primary: Numbers of Lesions With no Response — 8; 9 lesions — p=0.534
Phase 4 N=154 Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study
Disease Due to BK Polyomavirus · Kidney Transplant Infection
Primary: Occurrence of BK Viruria — 22; 26 Participants
Phase 4 N=101 Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations
Metastatic Non Small Cell Lung Cancer
Primary: Number of Participants With All-Causality and Treatment-Related Treatment-Emergent Adverse Events (TEAEs) — 94; 16; 92; 7 Participants
Phase 4 N=12 Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children
Influenza Vaccines
Primary: Type-specific Vaccine Virus Shedding in 2018/19 - Day 1 Post LAIV — 3 Participants